Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average (2016 - 2025)

Historic Assets Average for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to $1.3 billion.

  • Agios Pharmaceuticals' Assets Average fell 2234.63% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 2234.63%. This contributed to the annual value of $1.5 billion for FY2025, which is 1384.86% up from last year.
  • As of Q4 2025, Agios Pharmaceuticals' Assets Average stood at $1.3 billion, which was down 2234.63% from $1.4 billion recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Assets Average peaked at $2.2 billion during Q2 2021, and registered a low of $811.4 million during Q2 2024.
  • In the last 5 years, Agios Pharmaceuticals' Assets Average had a median value of $1.3 billion in 2022 and averaged $1.4 billion.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 14568.32% in 2021, then crashed by 4067.6% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Assets Average (Quarter) stood at $1.5 billion in 2021, then decreased by 18.8% to $1.2 billion in 2022, then dropped by 19.62% to $972.2 million in 2023, then skyrocketed by 77.69% to $1.7 billion in 2024, then decreased by 22.35% to $1.3 billion in 2025.
  • Its Assets Average was $1.3 billion in Q4 2025, compared to $1.4 billion in Q3 2025 and $1.5 billion in Q2 2025.